Investigating the effect of JAKi ruxolitinib in a murine breast cancer model Bottos et al. showed a JAKi-induced impairment of NK cell-mediated tumor immunosurveillance and enhanced metastasis formation, which were overcome by immunostimulation with IL-15 [74]. This evidence concerns the gene IL15 and breast carcinoma.